Deja Vu: Phossy Jaw

Q: How does phosphorus cause ‘Phossy Jaw’?



A: So, ‘phossy jaw’ is essentially a form of osteonecrosis of the jaw bone. It predominantly affects the lower jaw and was seen first in matchstick factory workers in the 19th century, as they were exposed to high amounts of white phosphorus.

To understand the pathophysiology of phossy jaw, we must know how bone is maintained in our body.



Bone matrix is synthesized by specialised cells called osteoblasts and remodelled (destroyed to make better bone) by osteoclasts.


Both osteoblasts and osteoclasts are vital for maintenance of bone mass, especially after bone injury for proper healing!

Now what one must know is that the function of osteoclasts is affected by a number of factors, and one class of compounds that inhibit their activity is bisphosphonates.

White phosphorus, with water, oxygen and an acidic environment in the presence of organic amino acids like lysine, gets converted to potent bisphosphonates. [1]



So when the bone is injured by trauma, tooth extraction or even daily wear or tear, osteoclasts are essential for the bone remodelling process, which is inhibited by bisphosphonates.[1]

Also, bisphosphonates prevent angiogenesis (development of new blood vessels) that impairs formation of new bone in these patients! [2]

This disease that was seen is matchstick factory workers is called BONJ (Bisphosphonate associated osteonecrosis of jaw) and was fully understood 200 years later after the disease was rediscovered in patients taking bisphosphonates as a therapy for osteoporosis!
(as bisphosphonates inhibit osteoclast activity, this effect is desirable in patients with low bone mass)

Hence as new bones is not formed and remodelling isn’t done adequately, the jaw becomes severely deformed and painful. History repeated itself when these patients had the same features as those who had occupational exposure to phosphorus at matchstick factories; hence some call this the second epidemic of the disease!

Nowadays, regulations mandate jaw protection and scrupulous dental hygiene for workers exposed to white phosphorous!

By Dr Ashwin Mahesh

References:


[1] Uncovering the cause of "phossy jaw" Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed.Marx RE. J Oral Maxillofac Surg. 2008.
J Oral Maxillofac Surg. 2008 Nov;66(11):2356-63. doi: 10.1016/j.joms.2007.11.006.
[2] Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice.Yanming Bi, Yamei Gao, and Li Zhang
Am J Pathol. 2010 Jul; 177(1): 280–290. doi:  10.2353/ajpath.2010.090592 PMCID: PMC2893671 PMID: 20472893
[3] Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23:8580–8587. [PubMed]

[4] Ruggiero SL, Woo SB. Bisphosphonate-related osteonecrosis of the jaws. Dent Clin North Am. 2008;52:111–128. [PubMed]

[5] Kuehn BM. Reports of adverse events from bone drugs prompt caution. JAMA. 2006;295:2833–2836. [PubMed]

[6] Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753–761. [PubMed]

[7] Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E. Bisphosphonate-associated osteonecrosis of the jaw: report

Comments

Post a Comment

Popular posts from this blog

The Icebreaker: Contraction Alkalosis

Image
The Icebreaker: What is Contraction alkalosis ?? The word 'contraction' in contraction alkalosis refers to fluid contraction or in other words, fluid loss . So when the body loses fluid (typically seen with diuretics) it tries to get all that fluid back. Q: How can the body do this ?   A: By increasing the serum sodium concentration. (increased sodium concentration --> increased osmolarity of serum --> increase in intravascular volume) Q: How does the body do it ? A:1) The decreased blood volume is sensed as decreased blood pressure felt by the kidneys at the glomerulus ie. decreased renal perfusion pressure. There are modified smooth muscle cells in the afferent arteriole that detect this change called JG cells . They secrete Renin in response to the low pressures.  2) By the diagram shown below Renin activates an axis that gives rise to Angiotensin II and aldosterone.   The Renin-Angiotensin-Aldosterone axis   3) Angiotens
Read more

Dexametha-Zone

Image
Q: What is the importance of Low Dose and High Dose Dexamethasone Suppression Tests? A: Let's begin with the HPA (Hypothalamus-Pituitary-Adrenal) axis: Cortisol suppresses the release of both CRH from the hypothalamus as well as ACTH from the pituitary. Low Dose Dexamethasone Test: The Overnight DST which is a type of Low Dose DST is used to rule out a hypercortisolism state or the diagnosis of Cushing’s syndrome. It is based on the principle that in a normal individual a low dose of dexamethasone is sufficient to suppress the ACTH production and hence the cortisol levels. Procedure: Overnight Dexamethasone test : 1 mg of Dexamethasone is given at 11pm and the cortisol level is measured at 8am. Failure to suppress the cortisol level to less than 50 nmol/L signifies Cushing's syndrome. LDDST : 0.5mg Dexamethasone q6h for 2 days and then the plasma cortisol is measured. Plasma cortisol more than 50 nmol/L is considered abnormal. Any abnormalit
Read more

Are SGLT2 inhibitors renoprotective?

Image
SGLT2 Inhibitors and Renoprotection Q: “How do SGLT2 inhibitors help in chronic kidney disease?” A: The renoprotective effect of SGLT2 inhibitors is still being extensively studied, but the results have been very promising. Let’s start with discussing what SGLT2 inhibitors are. SGLT 2 inhibitors SGLT2 inhibitors (eg dapagliflozin, canagliflozin, empagliflozin etc) are a class of drugs that inhibit reabsorption of glucose in the kidney (by inhibiting the sodium-glucose transport protein 2 - ie, SGLT2) and therefore lower blood sugar. Because of their use in lowering blood glucose levels, they are regularly used in the management of type 2 diabetes mellitus (and increasingly in type 1 diabetes as well). In addition to glycemic control, they have been shown to provide significant cardiovascular benefit in patients with type 2 diabetes. Mechanism Sodium Glucose cotransporters (SGLTs) are proteins that are found in different tissues that play an important role in mai
Read more